Efficacy of gabapentin therapy in children with refractory partial seizures☆,☆☆,★
Section snippets
Study design
We reviewed the records of all children (1 to 18 years) with intractable partial seizures treated at The Children's Hospital, Boston, Massachusetts, from January 1994 through September 1994. Institutional review board approval was obtained. Patients included in this study fulfilled the specific inclusion criteria as follows: (1) pediatric age group (ages 1 to 18 years), (2) intractable partial seizures that persisted despite appropriate trials of at least three of the first-line AEDs used as
Patient profile
The study population consisted of 32 patients (17 male patients and 15 female patients) with a mean age of 7.1 years (range 2 to 16 years). Eleven (34.4%) were older than 10 years of age and 21 (65.6%) were younger than 10 years. All 21 patients who were younger than 10 years were mentally retarded, and 5 of the 11 patients older than 10 also were retarded. Seventeen patients (53.1%) had moderate to severe mental retardation, nine (28.1%) had mild retardation, and six (18.8%) had normal
DISCUSSION
Our experience indicates that gabapentin can be an effective adjunctive AED in children with refractory partial seizures. About a third of the patients had a greater than 50% reduction in seizure frequency, and two patients became seizure free. These results are similar to the data reported in the various clinical trials of gabapentin therapy in adults.4, 5, 6, 7, 8, 9, 10, 11, 12 In the five randomized, double-blind, placebo-controlled clinical trials in adults, the responder rate (percentage
Acknowledgements
We thank Lorraine Sardano for her assistance in preparing the manuscript.
References (23)
Gabapentin in partial epilepsy
Lancet
(1990)- et al.
The efficacy of felbamate in refractory partial seizures in children
J Pediatr
(1994) - et al.
The epidemiology of epilepsy in Rochester, Minnesota, 1935 through 1967
Epilepsia
(1975) Epidemiology of different types of epilepsy in school age children of Modena, Italy
Epilepsia
(1980)Clinical evolution and prognosis of childhood epilepsies
Epilepsia
(1982)Clinical efficacy and safety of gabapentin
Neurology
(1994)- et al.
Gabapentin: a review of its pharmacological properties and clinical potential in epilepsy
Drugs
(1993) - et al.
Gabapentin as an antiepileptic drug in man
J Neurol Neurosurg Psychiatry
(1987) - et al.
Double blind study of gabapentin in the treatment of partial seizures
Epilepsia
(1991) - et al.
Efficacy and safety of gabapentin (Neurontin): a multicenter, placebo-controlled, double-blind study (abstract)
Neurology
(1991)
Gabapentin as add-on therapy in refractory partial epilepsy: a double-blind, placebo-controlled, parallel-group study
Neurology
Cited by (97)
Retention rate of Gabapentin in children with intractable epilepsies at 1 year
2012, SeizureCitation Excerpt :The results of those continuing treatment throughout the three observation periods of 2 < 6, 6 < 12 and 12+ months since commencing treatment are the most useful measure of how GAB performed in terms of efficacy and tolerability in the paediatric cohort. The results of this study support the findings of tolerability and efficacy of similar studies of children with intractable epilepsies on GAB.10 Seizure freedom was achieved in 6% started on GAB, 3 of whom had focal epilepsy of unknown aetiology, 1 with symptomatic focal epilepsy, 1 with cryptogenic focal epilepsy and one patient with idiopathic generalised epilepsy.
Retention rate of Clobazam, Topiramate and Lamotrigine in children with intractable epilepsies at 1 year
2011, SeizureCitation Excerpt :These results demonstrate that a substantial number of young patients with intractable epilepsies will benefit from treatment with CLB or LAM, and a reasonable number may benefit from treatment with TOP, whatever the epilepsy category. The methods used in this study are comparable to those used in other studies of newer AEDs like Levetiracetam, Zonisamide, and Gabapentin19–21 so the results may be compared to the performance of those drugs in intractable epilepsies in the paediatric population. Our study confirms the efficacy, tolerability and safety profile of CLB, TOP and LAM in a paediatric cohort with intractable epilepsies.
Pain Assessment and Management
2011, Textbook of Interdisciplinary Pediatric Palliative CareChoosing the Correct Antiepileptic Drugs: From Animal Studies to the Clinic
2008, Pediatric NeurologyCitation Excerpt :Likewise, AEDs may possess age-related toxicity. The likelihoods of lamotrigine-induced rash [53], gabapentin-induced behavioral abnormalities [54,55], phenobarbital-induced hyperactivity [56], and valproate-induced hepatotoxicity [57,58] are all greater in children than in adults. Despite these age-related unique features of AEDs, the majority of AEDs used in children are the same as those used in adults.
How does one choose the correct pharmacotherapy for a pediatric patient with restless legs syndrome and periodic limb movement disorder?: Expert Guidance
2019, Expert Opinion on Pharmacotherapy
- ☆
From the Epilepsy Program, Department of Neurology, Children's Hospital, Harvard Medical School, Boston, Massachusetts, and the Department of Pediatrics, American University of Beirut, Lebanon
- ☆☆
Reprint requests: Mohamad Mikati, MD, Department of Pediatrics, American University Hospital, c/o American University of Beirut New York Office, 850 Third Ave., 18th Floor, New York, NY 10022.
- ★
0022-3476/96/$5.00 +0 9/20/73088